Alzheimers Clinics

First evidence of long-term effects of transcranial pulse stimulation (TPS) on the human brain

"Findings suggest that TPS induces neuroplastic changes that go beyond the spatial and temporal stimulation settings. This evidence of sham-controlled long-term effectivity, safety and feasibility encourages further clinical applications of TPS"

https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-03222-5

First evidence of long-term effects of transcranial pulse stimulation (TPS) on the human brain - Journal of Translational Medicine Background With the high spatial resolution and the potential to reach deep brain structures, ultrasound-based brain stimulation techniques offer new opportunities to non-invasively treat neurological and psychiatric disorders. However, little is known about long-term effects of ultrasound-based bra...

Drug rejected in the EU

https://www-bbc-co-uk.cdn.ampproject.org/c/s/www.bbc.co.uk/news/health-59699907.amp

Controversial Alzheimer's drug rejected by EU - BBC News Charities are disappointed but regulators say there is still little evidence of the drug's benefit.

NeuroPulse TPS 3D visualisation:

The NEUROLITH® BodyTrack® software allows easy and quick calibration of the patients head shape with
the patient MRI or CT data. The user can define the treatment areas and target regions individually.

A diagnosis of Alzheimer’s disease brings many challenges – both for those with the disease and for their family members. Despite the best efforts of medical science, Alzheimer’s disease remains incurable.

However, particularly in recent years, progress has been made in the fight against this condition and it’s associated symptoms. For more information on how NeuroPulse TPS can help your loved ones visit our website.

London Alzheimer’s Clinic is situated at 100 Harley Street, London Treatments are supervised by renowned consultant psychiatrist Dr Mohamed Abdelghani. For further information, eligibility requirements, or to book a consultation visit www.alzheimersclinics.co.uk

Many people affected by dementia face catastrophic care costs - Alzheimer's Society.

Many families pay up to £1000 per week for care, sometimes even more, out of their own pocket.

https://youtu.be/-n7dh3rHlB0

Dementia Care: it’s taking everything Based on a true story, Alzheimer’s Society’s animation depicts the emotional and financial social care costs that are having devastating impacts on families ...

Alzheimers Clinics updated their address.

"Alzheimer's is a very prevalent disease and unfortunately the available treatments have limited effectiveness. Therefore, our team is very excited to be the first clinic in the UK to offer NeuroPulse TPS a non-invasive drug-free treatment to patients who are struggling with Alzheimer's disease" Dr Mohamed Abdelghani, Consultant Psychiatrist.

In the press - checkout the latest article in The Express 🗞️

Alzheimer’s breakthrough as revolutionary drug-free treatment available in UK!

https://hubs.ly/Q011-XVH0

Alzheimer’s breakthrough as revolutionary drug-free treatment available in UK FOR the first time, a UK clinic is offering a revolutionary new treatment for Alzheimer's disease and dementia which is drug-free.

Transkranielle Pulsstimulation TPS ✨

Die TPS nimmt derzeit einen recht großen Teil meiner Arbeit ein. Hätte mir das jemand vor einigen Jahren gesagt, dass ich in meiner Ordination auch Alzheimer-Patienten behandle, hätte ich ihn wahrscheinlich ausgelacht.

Es sind aber nicht nur die physischen Erfolge, bei denen es sich auszahlt. Nein, die individuellen Momente, die grandiosen Geschichten von jedem Einzelnen, die machen meine Arbeit so abwechslungsreich 🤩🙏

Researchers have identified a link between misshapen, fast replicating tau proteins, and accelerated cognitive decline. The findings shed new light on the development and progression of Alzheimer's disease.

https://neurosciencenews.com/tau-alzheimers-progression-19886/

Findings Open the Way to More Precise Diagnoses and Treatments of Alzheimer’s Disease - Neuroscience News Researchers have identified a link between misshapen, fast replicating tau proteins, and accelerated cognitive decline. The findings shed new light on the development and progression of Alzheimer's disease.

Research published this week in the Lancet Public Health, predicts that the estimated number of people with dementia will increase from 57.4 million in 2019 to 152.8 million by 2050, an increase of almost 200%.

https://alzheimersclinics.co.uk/global-dementia-prevalence/

Dementia cases expected to almost triple globally by 2050 Research published this week in the Lancet Public Health, predicts that the estimated number of people with dementia will increase from 57.4 million in 2019 to 152.8 million by 2050, an increase of almost 200%. The research, which was funded by the Bill and Melinda Gates Foundation, suggests that tr...

Wir haben gute Neuigkeiten! Die Transkranielle Pulsstimulation (TPS) mit NEUROLITH® zeigt ihre Wirkung nicht nur bei der Behandlung der Patient*innen, sondern der steigende Bekanntheitsgrad bewirkt auch, dass mehr und mehr Kliniken und Ärzt*innen auf die TPS aufmerksam werden – mit der Folge, dass sukzessive weitere TPS-Zentren hinzukommen. Dies gilt sowohl für Deutschland als auch für Österreich und die Schweiz (und auch andere Länder in Europa bzw. weltweit). Ab Montag, den 13.12.21 werden sich viele unserer Besucher*innen sicher freuen, denn dann veröffentlichen wir die neuesten Anwender*innen im Januar/Februar 2022 und deren Standorte. Darüber hinaus möchten wir aus gegebenem Anlass noch einmal anmerken, dass es sich bei der Transkraniellen Pulsstimulation (TPS) um eine REGENERATIVE THERAPIE bzgl. des zentralen Nervensystems handelt. Oft werden wir jetzt auch zu Indikationen wie Multiple Sklerose, Polyneuropathie, Schlaganfall, Lähmungen etc. befragt – eine durchaus berechtigte, in der Konsequenz logische Frage. An der TPS zur Behandlung von Demenz wurde über 20 Jahre (!) geforscht und die Forschung ist mit der Zulassung des NEUROLITH® natürlich nicht beendet. Was in der Zukunft noch mit der TPS erreicht werden kann, lest Ihr in unserem Interview mit dem „Vater der TPS“, Dr. med. Henning Lohse-Busch: https://www.alzheimer-deutschland.de/aktuelles/interviews/interview-dr-med-henning-lohse-busch-teil2

Dr Boris Kawliche from Brandon TMS & Psychiatry shares the results achieved with Jane, a 94 year old patient with Alzheimer's disease.

Jane has been given a new lease on life and has regained some of her independence. Read Jane's full story through the link below.

https://www.linkedin.com/posts/activity-6870872153647132672-EKwA